ECL SEC Filings

Ecolab Inc. (ECL) announced on May 29, 2026, the successful completion of a significant debt offering, raising a total of $5.0 billion across four series of notes: $1.2 billion in 4.600% Notes due 2029, $900 million in 4.800% Notes due 2031, $1.5 billion in 5.150% Notes due 2033, and $1.4 billion in 5.350% Notes due 2036. The proceeds from this offering are earmarked to fund the acquisition of Frigeo Holdings LLC (CoolIT Systems) and for general corporate purposes, which may include debt repayment. The offering was structured under the company's effective shelf registration statement and involved a series of agreements, including an underwriting agreement with major financial institutions. The notes are governed by an indenture that includes covenants restricting the company's ability to incur liens, engage in sale-leaseback transactions, and transfer certain subsidiary assets. Notably, certain notes (2029, 2031, and 2033) are subject to a special mandatory redemption if the CoolIT Systems acquisition does not close by a specified date or if the merger agreement is terminated. Additionally, change of control events could trigger a mandatory repurchase offer for the notes.

Ecolab Inc. (ECL) filed an 8-K on May 11, 2026, reporting key personnel changes and the outcomes of its Annual Meeting held on May 7, 2026. The most significant executive update is the appointment of Bryce L. Mewhorter as Senior Vice President and Corporate Controller, effective after the Q2 2026 10-Q filing. Mr. Mewhorter, a long-tenured employee with extensive financial experience within the company, will assume the principal accounting officer role. Jennifer J. Bradway will transition to a new role within Ecolab after supporting Mr. Mewhorter's transition. The Annual Meeting saw strong shareholder support for the election of all 13 director nominees, the advisory approval of executive compensation, and the ratification of PricewaterhouseCoopers LLP as the independent auditor for 2026. However, a shareholder proposal for an independent board chair policy was not approved. These events indicate continuity in leadership and governance, with a focus on internal talent development for critical financial roles.

Ecolab Inc. (ECL) reported a strong first quarter for 2026, with net sales increasing by 10% year-over-year to $4.07 billion. This growth was driven by a 4% increase in organic sales, reflecting solid performance across all reportable segments, particularly in Global Life Sciences (11% organic sales growth) and Global Pest Elimination (7% organic sales growth). The company's operating income rose by 12% to $622 million, and net income attributable to Ecolab grew by 7% to $432.6 million, translating to diluted EPS of $1.52. The company also announced its agreement to acquire CoolIT Systems for $4.75 billion, a move that is expected to close in the third quarter of 2026 and represents a significant strategic expansion into data center liquid cooling solutions. While the company faced increased interest expenses and higher commodity costs, these were partially offset by pricing actions, productivity gains, and favorable foreign currency translation. Ecolab also continues to manage its restructuring initiatives, "One Ecolab," which is on track to deliver significant annualized cost savings. Investors should note the increase in short-term debt primarily due to funding for recent acquisitions, and the company's ongoing commitment to returning capital to shareholders through dividends and share repurchases.

Ecolab Inc. (ECL) filed an 8-K on April 28, 2026, to report its first-quarter financial results for the period ended March 31, 2026. The filing primarily serves to announce the earnings release and related supplemental data, which are furnished as exhibits (99.1 and 99.2) and incorporated by reference. These documents are crucial for investors seeking details on the company's recent performance and outlook. While the 8-K itself does not provide detailed financial figures, it directs investors to the accompanying press release and supplemental data for this information. Investors should review these furnished exhibits to understand Ecolab's revenue, profitability, and any key operational metrics for the first quarter. The company also included a standard cautionary statement regarding forward-looking information, highlighting potential risks and uncertainties that could impact future results, particularly concerning any ongoing or planned restructuring initiatives.

Ecolab Inc. (ECL) has filed an 8-K report on April 15, 2026, announcing the execution of a $4.75 billion unsecured delayed draw term loan credit facility. This facility, finalized on April 10, 2026, is specifically designated to finance the acquisition of Frigeo Holdings LLC and related expenses, as well as to refinance existing Frigeo debt. This move signals a significant strategic step for Ecolab in expanding its operations through this acquisition. The credit facility offers flexible borrowing options, including Term SOFR, Daily Simple SOFR, and Base Rate loans, with interest rates tied to Ecolab's credit ratings and ranging from approximately 0.75% to 0.875% plus applicable margins. The agreement includes a financial covenant requiring Ecolab to maintain a minimum interest expense coverage ratio, alongside customary covenants and events of default. Investors should note that while this facility provides substantial funding for a key acquisition, it also introduces new debt obligations and associated financial covenants that will need to be managed.

Ecolab Inc. (ECL) has filed a Current Report on Form 8-K to provide investors with supplemental unaudited reportable segment information for the years ended December 31, 2025 and 2024. This filing includes a restatement of segment data at fixed currency exchange rates established at the beginning of 2026, allowing for a clearer view of operational performance independent of foreign currency fluctuations. Additionally, the report details changes to Ecolab's segment reporting structure, effective from the first quarter of 2026, which will impact how the company reports its financial results going forward. The most significant change is the division of the former 'Light & Heavy' operating segment into three new segments: 'Heavy Water,' 'Light Water,' and 'High-Tech,' all of which remain within the Global Water reportable segment. This structural adjustment, along with the movement of certain customers and cost allocations, results in Ecolab now reporting nine operating segments. Investors should note that this information is supplemental and intended to provide enhanced transparency, not to replace previously filed financial statements.

Ecolab Inc. (ECL) announced on March 20, 2026, that it has entered into a definitive agreement to acquire CoolIT Systems. This strategic acquisition is a significant development for Ecolab, likely aimed at expanding its capabilities and market reach within its core business segments, potentially in areas related to cooling technologies and solutions for data centers or industrial processes, given CoolIT's specialization. In addition to the acquisition news, Ecolab also updated its earnings guidance in conjunction with this announcement. While the specific details of the guidance update are not provided in the 8-K itself, investors should refer to the furnished News Release (Exhibit 99.1) for precise figures and projections. This guidance update, coupled with the acquisition, suggests management's outlook on future performance and strategic growth initiatives.

Ecolab Inc. (ECL) announced a significant leadership realignment effective April 1, 2026. The company appointed Christophe Beck to the new role of President, while retaining his existing CEO and Chairman responsibilities. Additionally, Darrell R. Brown and Gregory B. Cook have been named Co-Chief Operating Officers, overseeing Global Markets and Global Businesses, respectively. This move appears to be a strategic step to further structure the executive team for operational efficiency and global reach, particularly with Mr. Brown's relocation to Australia to head global markets. The appointments reflect a deepening of leadership responsibilities for seasoned executives with extensive tenures at Ecolab. Mr. Brown, previously President and COO, will now focus on international operations, while Mr. Cook, with a strong background in the Institutional Group and finance, will lead global business units. The compensation structures for Mr. Brown and Mr. Cook indicate substantial annual incentives and long-term equity awards, aligning their rewards with company performance and long-term value creation. Investors should monitor how these new roles impact operational execution and financial performance.

Ecolab Inc. (ECL) reported solid performance for the year ended December 31, 2025, with record sales, operating income margin, adjusted diluted earnings per share, and free cash flows. The company's reported sales increased by 2% to $16.1 billion, driven by organic sales growth across its key segments, particularly Global Pest Elimination and Global Life Sciences. This growth was supported by strong value pricing and improved productivity, which helped offset investments in the business. The company also highlighted its commitment to returning capital to shareholders, increasing its quarterly dividend by 12% and continuing its long history of dividend payments. The acquisition of Ovivo Electronics for $1.6 billion in December 2025 was a significant event, intended to bolster the company's offerings in the semiconductor manufacturing sector within the Global Water segment. Despite challenges from global economic and geopolitical factors, Ecolab maintained strong financial health, with credit ratings of A-/A3/A- and a commitment to maintaining 'A' range credit metrics. The company's strategic initiatives, including the "One Ecolab" program, aim to further enhance growth and margin expansion through digital technology and operational efficiencies.

Ecolab Inc. (ECL) announced that Victoria J. Reich will not be standing for re-election at the company's upcoming annual meeting on May 7, 2026. This decision, communicated to the Board on February 18, 2026, is not attributed to any disagreements with the company. Ms. Reich has served on the Board for several years, and the Board expressed gratitude for her contributions.

Ecolab Inc. (ECL) filed an 8-K on February 10, 2026, primarily to announce updates regarding its financial condition and a significant restructuring initiative. While the filing doesn't detail fourth quarter 2025 earnings, it incorporates by reference a news release and supplemental data that do. Investors should note the expansion of the "One Ecolab" initiative, which includes a substantial restructuring plan aimed at leveraging digital technologies and creating global centers of excellence. This plan is expected to incur significant costs but is positioned as a driver for future growth and margin expansion.

Ecolab Inc. reported a net sales increase of 4% to $4,165.0 million for the third quarter of 2025, reaching $11,885.2 million for the first nine months, a 1% increase year-over-year. While reported operating income saw a significant decrease of 27% in the third quarter due to a large gain on the sale of its global surgical solutions business in the prior year, adjusted operating income showed a healthy 10% increase. Net income attributable to Ecolab decreased by 21% to $585.0 million in the third quarter, but adjusted net income saw a 13% increase. Diluted EPS also reflected this trend, with reported EPS down 21% but adjusted diluted EPS up 13%. The company continues to invest in growth initiatives, as evidenced by increased SG&A expenses relative to sales in the third quarter. The "One Ecolab" initiative is progressing, with expanded restructuring plans anticipated to yield significant cost savings. Ecolab also announced its agreement to acquire Ovivo Electronics for approximately $1.8 billion, signaling a strategic move into the semiconductor manufacturing water technology sector. The company maintains a strong balance sheet with increased cash and cash equivalents, and its leverage ratios remain stable.

Ecolab Inc. (ECL) has filed an 8-K report on October 28, 2025, announcing its financial results for the third quarter ended September 30, 2025. The filing primarily serves to attach and incorporate by reference the press release and supplemental data related to these results. Investors should refer to Exhibit 99.1 (News Release) and Exhibit 99.2 (Supplemental Data) for detailed financial performance, operational updates, and forward-looking statements. The company's announcement provides the market with its latest performance figures, which are crucial for assessing the company's trajectory and making informed investment decisions. While the 8-K itself is a procedural filing, the attached exhibits contain the substantive information regarding Ecolab's financial condition and results of operations for the third quarter.

Ecolab Inc. (ECL) has filed an 8-K detailing the successful completion of a public offering of $500 million aggregate principal amount of 5.000% Notes due 2035. The offering, underwritten by Citigroup Global Markets Inc., J.P. Morgan Securities LLC, and Wells Fargo Securities, LLC, was completed on August 27, 2025. The net proceeds from this issuance are intended for general corporate purposes, which may include funding a portion of the previously announced acquisition of Ovivo Inc.’s Electronics business and repaying outstanding commercial paper or other debt. This debt issuance provides Ecolab with significant capital to execute its strategic growth initiatives and manage its existing financial obligations.

Ecolab Inc. (ECL) reported solid financial results for the second quarter and first six months of 2025. Net sales saw a modest increase of 1% year-over-year, reaching $4,025.2 million for the quarter, with organic sales up 3%. This growth was driven by increases across most of its reporting segments, including Global Water, Global Institutional & Specialty, Global Pest Elimination, and Global Life Sciences, underscoring the company's ability to maintain pricing power and expand its market reach. Profitability showed a notable improvement, with reported operating income increasing by 8% to $710.1 million for the quarter. Net income attributable to Ecolab rose by 7% to $524.2 million. The company also highlighted strong performance in adjusted metrics, with adjusted diluted EPS increasing by 13% to $1.89, reflecting effective cost management and operational efficiencies, particularly from the 'One Ecolab' initiative. The balance sheet remains robust, with a strong cash position and manageable debt levels, supporting ongoing capital expenditures and shareholder returns.

Ecolab Inc. (ECL) has announced a significant addition to its Board of Directors with the appointment of Julie P. Whalen, effective August 6, 2025. Ms. Whalen brings a wealth of financial expertise, having previously served as Executive Vice President and Chief Financial Officer for Expedia Group, Inc. and Williams-Sonoma, Inc. Her extensive experience in financial planning, corporate control, treasury, and audit committee leadership, including her tenure as Chair of Expedia's Audit Committee, is expected to be a valuable asset to Ecolab's governance and strategic direction. Ms. Whalen's appointment to the Board, as well as her placement on the Audit and Finance Committees, underscores the company's commitment to robust financial oversight and strategic financial management. Her qualifications as a Certified Public Accountant and her Juris Doctor degree further enhance her suitability for these critical roles. Investors should view this appointment as a positive development, indicating a focus on strengthening the company's financial acumen at the highest levels of leadership.

Ecolab Inc. (ECL) has filed an 8-K report on July 29, 2025, to announce its financial results for the second quarter ended June 30, 2025. The filing incorporates by reference the company's official press release (Exhibit 99.1) and supplemental data (Exhibit 99.2) used in conjunction with its conference call. These documents provide detailed insights into the company's performance during the quarter. Investors should refer to the furnished exhibits, which will also be available on Ecolab's website, for comprehensive financial and operational details. While this 8-K primarily serves as an announcement mechanism for the earnings release and supplemental information, it signifies a key update on the company's ongoing financial condition and operational results.

Ecolab Inc. (ECL) has announced the resignation of its Executive Vice President and Chief Supply Chain Officer, Machiel Duijser, effective July 25, 2025. Mr. Duijser is departing to pursue a senior executive role at another publicly traded company. Importantly, the company states that his resignation is not a result of any disagreements regarding Ecolab's operations, policies, or practices. This indicates a voluntary departure, which is generally viewed favorably by investors as it avoids potential signs of internal turmoil. Investors should note that Ecolab has a succession plan in place and will be appointing an internal successor for this critical role. While the name of the successor is not yet disclosed in this filing, the emphasis on an internal appointment suggests continuity and a stable leadership transition. The supply chain function is vital for a company like Ecolab, and the market will likely be watching closely to see how this leadership change impacts operational efficiency and future strategic execution.

Ecolab Inc. (ECL) has announced the completion of a $500 million offering of its 4.300% Notes due 2028. The net proceeds from this issuance are designated for general corporate purposes, which may include the repayment of existing indebtedness. This debt offering, executed through an underwriting agreement with several representatives including Barclays Capital Inc. and BofA Securities, Inc., was made under the company's existing shelf registration statement. The notes bear a semi-annual interest rate of 4.300% and mature on June 15, 2028. This financing activity indicates Ecolab's ongoing capital management strategy. Investors should note the stated use of proceeds, which could signal a deleveraging effort or funding for general operational needs. The inclusion of standard covenants within the indenture provides some investor protections, such as limitations on liens and sale-and-leaseback transactions, and a provision for a mandatory repurchase offer in the event of a change of control.

Ecolab Inc. filed an 8-K on May 8, 2025, reporting on key events and outcomes from its Annual Meeting of Stockholders held on May 8, 2025. A significant development was the appointment of Marion K. Gross to the Board of Directors, effective May 7, 2025, and her subsequent election by stockholders at the Annual Meeting. Ms. Gross brings extensive supply chain and sustainability leadership experience from McDonald's, and her appointment is expected to enhance the Board's expertise. Furthermore, Ecolab's stockholders approved proposed amendments to the Restated Certificate of Incorporation, which aim to limit the liability of certain officers, aligning with Delaware law. The company also reported the election of 13 directors, the advisory approval of executive compensation, and the ratification of PricewaterhouseCoopers LLP as its independent auditor for fiscal year 2025. These announcements provide insights into corporate governance and operational continuity for investors.

Ecolab Inc. (ECL) has filed an amendment to its prior 8-K filing to provide updated information regarding committee appointments for its Board of Directors. Specifically, Michel Doukeris, who was appointed to the Board on February 20, 2025, has now been assigned to the Audit Committee and the Governance Committee. These appointments are effective as of May 8, 2025. While this filing does not contain new financial results or material strategic changes, it provides clarity on the board's governance structure. Investors can note that Mr. Doukeris, a key executive, is now integrated into important board oversight functions, including financial reporting oversight (Audit Committee) and corporate governance practices (Governance Committee). This reflects a standard practice for onboarding new board members into key committee roles.

Ecolab Inc. reported first-quarter 2025 results with net sales of $3,695.0 million, a 2% decrease compared to the prior year, primarily due to the divestiture of the global surgical solutions business and unfavorable currency translation. However, on a fixed currency basis, net sales increased by 1%, and organic sales grew by 3%. The company's operating income saw a healthy increase of 7% to $555.3 million, driven by strong organic growth across its segments and improved pricing strategies. Net income attributable to Ecolab was $402.5 million, a slight decrease of 2% year-over-year, while diluted EPS stood at $1.41. The company continues to make progress on its 'One Ecolab' initiative, which is designed to enhance growth and margin expansion, with significant restructuring charges impacting the current quarter. Despite these charges and ongoing macroeconomic uncertainties, Ecolab's diversified business model and focus on value pricing have supported its performance. Investors will be watching the execution of the 'One Ecolab' plan and its impact on future profitability and cash flow generation.

Ecolab Inc. (ECL) has filed an 8-K report on April 29, 2025, to announce its first-quarter financial results for the period ending March 31, 2025. While the 8-K itself does not contain the detailed financial figures, it explicitly references the accompanying News Release (Exhibit 99.1) and Supplemental Data (Exhibit 99.2) as the primary sources for this information. Investors should refer to these attached exhibits for a comprehensive understanding of Ecolab's performance during the first quarter of 2025. These exhibits, which are furnished with the report and will also be available on Ecolab's website (www.ecolab.com), are crucial for analyzing the company's operational and financial condition. The filing indicates that the company will hold a conference call to discuss these first-quarter results, further emphasizing the importance of the information contained within the referenced documents.

Ecolab Inc. (ECL) announced on March 27, 2025, that it has entered into a fourth amended and restated multicurrency credit agreement, establishing a new $2.0 billion unsecured 5-year revolving credit facility that matures in March 2030. This new facility replaces and extends the maturity of Ecolab's previous $2.0 billion credit facility, which was set to expire in April 2026. The primary purpose of this enhanced credit facility is to provide financial flexibility for general corporate purposes, including potential share repurchases, debt repayment, and strategic acquisitions. The agreement, with Bank of America, N.A. as administrative agent, offers various interest rate options for U.S. Dollar, Euro, Yen, and Sterling denominated loans, incorporating benchmarks like Term SOFR, EURIBOR, TIBOR, and SONIA. It also includes subfacilities for letters of credit and swing line loans. A key aspect for investors to note is the inclusion of a financial covenant requiring Ecolab to maintain a minimum interest expense coverage ratio, alongside customary covenants and events of default. This strategic move underscores Ecolab's commitment to maintaining robust liquidity and financial maneuverability.

Ecolab Inc. (ECL) has filed a Current Report on Form 8-K to provide investors with supplemental unaudited reportable segment information for the years ended December 31, 2024, and December 31, 2023. This filing includes data presented at fixed currency exchange rates established at the beginning of 2025, which aims to offer a clearer view of underlying business performance without the impact of currency fluctuations. Additionally, Ecolab is detailing significant changes to its segment reporting structure, effective from the first quarter of 2025. These segment realignments include renaming the Global Industrial segment to Global Water and incorporating specific sub-segments. The healthcare operating segment has been moved into the Institutional operating segment, and Global Life Sciences has been elevated to a standalone reportable segment. Investors should note that this information is supplemental and does not replace previously filed financial statements, but it provides valuable context for understanding the company's evolving operational structure and performance metrics.

Ecolab Inc. (ECL) reported strong financial performance for the fiscal year ended December 31, 2024, with record sales, operating income margin, free cash flow, and adjusted diluted earnings per share. The company achieved this through robust value pricing, lower delivered product costs, and increased volumes across its diverse segments, including Global Industrial, Global Institutional & Specialty, Global Healthcare & Life Sciences, and Global Pest Elimination. Key financial highlights include a 3% increase in reported sales to $15.7 billion and a significant 41% increase in reported operating income to $2.8 billion. Adjusted diluted EPS grew by 28% to $6.65. Ecolab also demonstrated a strong commitment to shareholder returns, increasing its quarterly cash dividend by 14% and maintaining a solid balance sheet with "A" range credit rating metrics. The company continues to invest in its business, evidenced by capital expenditures and strategic acquisitions, while also focusing on sustainability initiatives with ambitious GHG emission reduction goals.

Ecolab Inc. announced a significant change to its Board of Directors through an 8-K filing on February 20, 2025. The company appointed Michel Doukeris, the current Chief Executive Officer of Anheuser-Busch InBev SA/NV, as a new director. Mr. Doukeris brings extensive global leadership experience, particularly in commercial operations and leading large markets, which could offer valuable strategic insights to Ecolab's future growth and operational strategies. In addition to the new appointment, the filing also disclosed that director Arthur J. Higgins will not be seeking re-election at the upcoming annual meeting. While the departure is stated to be unrelated to any disagreements, it marks the end of Mr. Higgins' tenure, with the company expressing gratitude for his service. Investors should monitor how these board changes may influence future corporate governance and strategic direction.

Ecolab Inc. (ECL) has filed an 8-K report on February 11, 2025, to announce its fourth-quarter results for the period ended December 31, 2024. The filing primarily serves to furnish the company's earnings release (Exhibit 99.1) and supplemental data (Exhibit 99.2) which were made public on February 11, 2025. These documents, which are incorporated by reference into the 8-K, contain detailed financial information and operational highlights for the fourth quarter. Investors should refer to these attached exhibits for specific earnings figures, segment performance, and management's commentary on the financial condition and results of operations. While this 8-K does not contain new financial statements or other substantive disclosures beyond the earnings announcement, it formally communicates that the earnings release and supplementary data are available. Ecolab will also be publishing these exhibits on its corporate website, www.ecolab.com, for broader accessibility. The company has elected not to use the extended transition period for complying with new or revised financial accounting standards, as it is not an emerging growth company.

Ecolab Inc. (ECL) reported a strong third quarter for fiscal year 2024, demonstrating robust sales growth and significant improvements in profitability. Net sales increased by 1% to $3,998.5 million, with organic sales growing by 4%, indicating healthy underlying business momentum across its key segments. The company experienced notable margin expansion, with reported gross margin improving to 43.4% from 41.1% in the prior year period, driven by effective value pricing and lower delivered product costs. Profitability saw a substantial uplift, with reported operating income surging by 85% year-over-year to $1,044.8 million. Net income attributable to Ecolab more than doubled to $736.5 million, and diluted EPS rose by 83% to $2.58. These gains were bolstered by the significant gain on the sale of the global surgical solutions business, but even on an adjusted basis, the company showed solid growth, with adjusted diluted EPS increasing by 19%. Ecolab continues to execute on its strategic initiatives, including the 'One Ecolab' program aimed at driving growth and margin expansion, and maintains a strong liquidity position with substantial cash reserves and available credit facilities.

Ecolab Inc. (ECL) has filed an 8-K report on October 29, 2024, to announce its third-quarter financial results for the period ended September 30, 2024. The filing primarily serves to furnish the accompanying news release (Exhibit 99.1) and supplemental data (Exhibit 99.2) that were made public on October 29, 2024. These documents contain the detailed earnings information and will be available on Ecolab's website, offering investors insight into the company's recent performance. Investors should refer to the attached exhibits for specific financial metrics, including revenue, earnings per share, and any commentary from management regarding operational performance, segment results, and future outlook. The report does not contain new material business developments beyond the earnings announcement itself, but the supplemental data is likely to provide a deeper dive into key performance indicators and financial breakdowns relevant for valuation and strategic assessment.

Ecolab Inc. (ECL) reported strong financial results for the second quarter and first six months of 2024, demonstrating significant year-over-year growth in net sales and net income. Net sales increased by 3% to $3,985.8 million in the second quarter and 4% to $7,737.7 million for the first six months, driven by robust organic sales growth across key segments, particularly Global Institutional & Specialty and Global Pest Elimination. The company also saw a substantial increase in operating income, up 36% to $656.9 million for the quarter, reflecting improved gross margins due to lower supply chain costs and effective pricing strategies. The company successfully managed its cost of sales, leading to a notable improvement in gross margin to 43.8% in the second quarter of 2024, up from 39.4% in the prior year. Net income attributable to Ecolab surged by 49% to $490.9 million ($1.71 per diluted share) for the second quarter. This performance was bolstered by strategic initiatives and operational efficiencies, despite some ongoing restructuring costs. Ecolab also completed the sale of its global surgical solutions business on August 1, 2024, which is expected to result in a pre-tax gain.

Ecolab Inc. (ECL) has filed a Current Report (8-K) on July 30, 2024, primarily announcing its second-quarter 2024 results and a significant restructuring initiative. The company is launching the 'One Ecolab' initiative, aimed at enhancing growth and margin expansion. A key component of this initiative is a restructuring plan to centralize functional work into global centers of excellence, leveraging digital technologies. This plan is expected to incur substantial restructuring costs and special charges over the next few years. Investors should note the financial implications of the 'One Ecolab' initiative. Ecolab anticipates total restructuring costs of $175 million ($136 million after tax) and special charges of $50 million ($39 million after tax) by the end of 2027. These costs are largely expected to be cash expenditures, predominantly for severance related to team reorganization. While the report focuses on these forward-looking initiatives and financial impacts, the specific financial results for the second quarter of 2024 are referenced through attached press releases and supplemental data, which would require further review for detailed performance metrics.

Ecolab Inc. (ECL) filed an 8-K on May 6, 2024, detailing the results of its Annual Meeting of Stockholders held on May 2, 2024. The meeting saw strong support for the re-election of its 12-member Board of Directors and the ratification of PricewaterhouseCoopers LLP as its independent auditor for fiscal year 2024. Additionally, shareholders approved, on an advisory basis, the compensation of named executives. The meeting also addressed a shareholder proposal concerning an independent board chair policy, which did not receive majority support from the shareholders. This filing provides transparency on key corporate governance matters and shareholder voting outcomes.

Ecolab Inc. reported a strong first quarter for 2024, with net sales increasing by 5% year-over-year to $3.75 billion, driven by a 5% increase in organic sales. The company demonstrated significant profit growth, with reported operating income up 47% to $517.9 million and net income attributable to Ecolab soaring 77% to $412.1 million. This robust performance was supported by an improved gross margin of 43.3% (up from 38.3% in the prior year) due to lower delivered product costs and effective pricing strategies. The company's strategic focus on efficiency and pricing power appears to be paying off, leading to substantial earnings per share growth. Ecolab also managed its debt effectively, reducing total debt by approximately $630 million in the quarter and maintaining a healthy net debt to EBITDA ratio of 2.2. Looking ahead, Ecolab has agreed to sell its global surgical solutions business for $950 million, which is expected to close in the second half of 2024 and generate a pre-tax gain, further strengthening its financial position and allowing for continued strategic investments.

Ecolab Inc. (ECL) has filed an 8-K report on April 30, 2024, to announce its financial results for the first quarter ended March 31, 2024. The report primarily serves to furnish the accompanying earnings release and supplemental data, which are incorporated by reference and will be available on the company's website. While the 8-K itself does not contain detailed financial figures, it directs investors to these supplementary documents for a comprehensive understanding of the company's performance during the quarter. Investors should refer to Exhibit (99.1), the News Release, and Exhibit (99.2), the Supplemental Data, for specific details on Ecolab's first-quarter operational and financial condition. These attached exhibits are crucial for evaluating the company's recent performance, trends, and any forward-looking statements or guidance provided by management.

Ecolab Inc. (ECL) filed an 8-K on March 15, 2024, to provide supplemental unaudited segment net sales and operating income information for the years ended December 31, 2023, and December 31, 2022. This filing importantly includes data reflecting international operations at fixed currency exchange rates established at the beginning of 2024, offering a clearer view of underlying operational performance by neutralizing currency fluctuations. Investors should note that this information is supplemental and not intended to replace previously filed financial statements but provides additional context for evaluating segment performance. The filing also details significant changes to Ecolab's segment reporting structure, effective January 1, 2024. The former Textile Care and Colloidal Technologies Group (CTG) segments have been integrated into the Water operating segment, which remains within the Global Industrial reportable segment. Additionally, the Pest Elimination segment, previously aggregated, is now reported as a standalone Global Pest Elimination reportable segment. These adjustments result in a new structure with eight operating segments and are reflected in the supplemental data provided.

Ecolab Inc. (ECL) announced a significant executive transition with the resignation of Lanesha T. Minnix, Executive Vice President, General Counsel and Secretary. Ms. Minnix is departing on April 1, 2024, to assume a chief legal officer role at another public company. Importantly, her resignation is stated to be amicable and not due to any disagreements concerning Ecolab's operations, policies, or practices. This leadership change in a key legal role warrants investor attention regarding the continuity and future direction of the company's legal and corporate governance functions.

Ecolab Inc. reported a strong financial performance for the year ended December 31, 2023, with net sales increasing by 8% to $15.3 billion and reported diluted Earnings Per Share (EPS) rising by 26% to $4.79. This growth was driven by robust pricing strategies across all segments, which effectively offset continued increases in delivered product costs. The company's operating income saw a significant 28% increase, reflecting improved gross margins and disciplined cost management. The company continues to prioritize its "Circle the Customer – Circle the Globe" strategy, emphasizing sustainability and innovation. Ecolab's commitment to reducing water and energy usage for its customers remains a core tenet of its business model, with significant progress made towards its 2030 water conservation goals. The company maintained strong financial health with a healthy balance sheet and generated substantial operating cash flow, enabling continued investment in business growth, debt repayment, and shareholder returns through dividends and share repurchases.

Ecolab Inc. (ECL) has filed a Current Report (8-K) on February 22, 2024, primarily announcing a change in its Board of Directors. The company appointed Judson Althoff, Executive Vice President and Chief Commercial Officer of Microsoft Corporation, as a new director, effective February 21, 2024. Mr. Althoff's extensive experience in commercial business and technology leadership is expected to be a valuable asset to Ecolab's Board, and he will serve on the Audit and Finance Committees. In addition, the report notes that director Barbara J. Beck will not be standing for re-election at the upcoming annual meeting on May 2, 2024. Ms. Beck is stepping down for personal family reasons and not due to any disagreements with the company. The Board expressed gratitude for her service. These board changes are the main focus of this filing, with no significant financial or operational updates provided at this time.

Ecolab Inc. (ECL) filed an 8-K on February 13, 2024, to report its fourth-quarter and full-year 2023 financial results. The filing primarily serves as a notification of the earnings release and related supplemental data, which are attached as exhibits. Investors should refer to the furnished News Release (Exhibit 99.1) and Supplemental Data (Exhibit 99.2) for detailed financial performance, operational highlights, and forward-looking statements. These documents, available on Ecolab's website, provide the comprehensive information regarding the company's recent financial condition and results of operations.

Ecolab Inc. (ECL) reported strong third quarter and year-to-date results for 2023, demonstrating resilience and growth across its key segments. Net sales increased by 8% year-over-year for both the quarter and the nine-month period, reaching $3.96 billion and $11.38 billion, respectively. This growth was driven by a combination of solid pricing actions and modest volume increases, reflecting the company's ability to pass on costs and the demand for its essential products and services. Profitability saw a significant improvement, with reported operating income up 17% in the third quarter and 19% year-to-date. Diluted EPS also showed robust growth, increasing 17% for the quarter to $1.41 and 17% year-to-date to $3.38. The company's improved gross margin, up to 41.1% in the third quarter from 37.5% in the prior year, highlights effective cost management and pricing strategies. The company also made significant progress on its restructuring programs, driving further efficiencies and contributing to the overall improved financial performance.

Ecolab Inc. (ECL) filed an 8-K report on October 31, 2023, primarily announcing its third quarter financial results for the period ended September 30, 2023. The report itself is brief, serving as a cover for the attached news release (Exhibit 99.1) and supplemental data (Exhibit 99.2), which contain the detailed financial performance and operational highlights. Investors should refer to these attached exhibits for comprehensive information regarding the company's performance during the third quarter.

Ecolab Inc. reported solid financial results for the second quarter and first six months of 2023, demonstrating revenue growth and improved profitability. Net sales increased by 8% year-over-year for both periods, driven by a combination of price increases and volume growth across most segments. The company saw particular strength in its Global Industrial and Global Institutional & Specialty segments, which experienced double-digit organic sales growth. Profitability also improved, with reported operating income up 14% and 23% for the respective periods. The company is actively managing restructuring initiatives aimed at cost savings, with a significant portion of the anticipated charges expected to be completed by 2024. Despite ongoing inflationary pressures and global economic uncertainties, Ecolab maintained a strong financial position. The company's liquidity remains robust, supported by consistent cash flow from operations. Management is focused on strategic growth initiatives, including targeted acquisitions, while also returning capital to shareholders through dividends and share repurchases. Ecolab's diversified business model and disciplined approach to cost management position it well to navigate the current economic landscape.

Ecolab Inc. (ECL) filed an 8-K on August 1, 2023, to announce its second-quarter financial results for the period ending June 30, 2023. The filing primarily serves to incorporate by reference the company's earnings release (Exhibit 99.1) and supplemental data (Exhibit 99.2) that were issued on the same date. These attached documents contain the detailed financial performance and operational highlights for the quarter. Investors should refer to the furnished exhibits for comprehensive information on Ecolab's performance, including key financial metrics, segment performance, and management's commentary. While the 8-K itself is procedural, the attached earnings materials provide the substance of the company's quarterly update, which is crucial for understanding the current financial health and outlook of Ecolab.

Ecolab Inc. (ECL) filed an 8-K on May 23, 2023, reporting a significant change in its Board of Directors. Jeffrey M. Ettinger, who served as Lead Director for the past six years and was a member of the Compensation & Human Capital Management and Governance Committees, resigned from the Board effective May 23, 2023. This resignation is a direct consequence of his appointment as the Interim President of the University of Minnesota. The company expressed gratitude for Mr. Ettinger's contributions and leadership, particularly during his tenure as Lead Director. Importantly, the filing clarifies that Mr. Ettinger's departure was not a result of any disagreements with Ecolab. This information is crucial for investors to understand leadership transitions and governance matters within the company.

Ecolab Inc. (ECL) filed an 8-K on May 9, 2023, detailing the outcomes of its Annual Meeting of Stockholders held on May 4, 2023. The primary focus for investors revolves around the approval of key proposals, including the new Ecolab Inc. 2023 Stock Incentive Plan, which authorizes the issuance of up to 20,000,000 shares of common stock for employee and director compensation. Additionally, the company secured stockholder ratification for its independent auditor, PricewaterhouseCoopers LLP, for the fiscal year ending December 31, 2023. The meeting also saw the election of 13 directors, the approval of an amendment to the Stock Purchase Plan, and a majority vote in favor of the advisory resolution on executive compensation. Importantly, stockholders approved holding the advisory vote on executive compensation on an annual basis. However, a stockholder proposal seeking an independent board chair policy was not approved.

Ecolab Inc. reported strong first-quarter 2023 results, demonstrating resilience and growth in a dynamic economic environment. Net sales increased by 9% year-over-year to $3.57 billion, driven by a 13% increase in organic sales, indicating robust underlying business performance. This growth was primarily fueled by effective pricing strategies across all segments, which more than offset increased delivered product costs. The company's operating income saw a significant increase of 38% to $351.6 million, reflecting improved operational efficiencies and strong sales execution. The company's diversified business segments, including Global Industrial, Global Institutional & Specialty, and Global Healthcare & Life Sciences, all contributed positively to the top-line growth, with particular strength noted in water treatment, food & beverage, and life sciences. Despite inflationary pressures and foreign currency headwinds, Ecolab maintained a disciplined approach to cost management and strategic investments, leading to a notable improvement in profitability. The company's balance sheet remains solid, with sufficient liquidity to support ongoing operations and strategic initiatives.

Ecolab Inc. (ECL) filed an 8-K on May 4, 2023, to report the immediate effectiveness of its Amended and Restated By-Laws, approved by its Board of Directors on May 3, 2023. These amendments are primarily to align the Company's governance documents with changes in the Delaware General Corporation Law (DGCL) and to enhance procedural clarity for stockholders and the Board. Key updates include refinements to adjournment procedures, stockholder list requirements, and consent procedures to reflect current DGCL provisions. The By-Laws also clarify quorum requirements for the Board, opt into specific DGCL sections regarding Board committees, and update advance notice provisions for director nominations and shareholder proposals. Additionally, changes were made to indemnification provisions, including expense advancements and the ability for indemnified individuals to sue for unpaid claims. These changes are designed to ensure compliance with legal standards and streamline corporate governance processes.

Ecolab Inc. (ECL) filed a Form 8-K on May 2, 2023, to report its first-quarter 2023 financial results. The filing primarily serves to provide access to the company's earnings release (Exhibit 99.1) and supplemental data (Exhibit 99.2) that were issued on the same date. These documents contain the detailed financial performance and operational insights for the quarter ended March 31, 2023. Investors should refer to the attached exhibits for comprehensive information on Ecolab's Q1 2023 performance, including revenue, earnings per share, segment performance, and any forward-looking guidance or strategic commentary provided by the company. The filing itself does not contain detailed financial tables but directs stakeholders to the furnished documents for material disclosures.

Ecolab Inc. (ECL) has filed a Current Report on Form 8-K on April 5, 2023, to provide investors with supplemental unaudited financial information related to its reportable segments for the years ended December 31, 2022 and 2021. This data is presented using fixed currency exchange rates established at the beginning of 2023, allowing for a clearer view of operational performance independent of currency fluctuations. Additionally, the report details immaterial changes to the company's segment reporting structure, notably the integration of the former Downstream segment into the Water operating segment, effective January 1, 2023. These adjustments result in a revised segment structure comprising ten operating segments. While this filing does not present new formal financial results, it offers valuable context for analyzing Ecolab's segment performance and understanding the impact of currency movements. Investors should note that this information is supplemental and furnished, not filed, and is intended to complement, not replace, the data provided in the company's official 10-Q and 10-K filings. The company will also publish these exhibits on its website.